Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
ng thi, bn nn chn mua sn phm ca thng hiu uy tn, c ngun gc r rng v c kim nh cht lng nghim ngt
Chalisova, N
Animal Model Evidence The systemic evidence base is entirely preclinical: Pulmonary fibrosis (mouse model): Intraperitoneal GHK-Cu at 0.2-20 micrograms/g/day protected against bleomycin-induced lung fibrosis by inhibiting TGF-beta1/Smad signaling and reducing oxidative stress (PMID 31809714)
In airways, epithelial cells and neutrophils are the main sources of ROS
Epithalon treatment significantly influences age-related disease incidence
US$ 23.66
US$ 21.02
US$ 22.01
US$ 24.57
US$ 24.41
